Dosing & Uses
Dietary Supplement
10 mg vanadyl sulfate yields 2 mg vanadium
The body contains between 20-25 mg and a regular diets provides about 2 mg/day
Typical dosage range: 50-100 mcg/day
Daily diet normally provides enough to meet requirements
Sources of vanadium: Dill, pepper, eggs, radishes, vegetable oils, buckwheat and oats
Potential health benefits: May improve sensitivity to insulin in type 1 and 2 diabetes; may also lower cholesterol levels and blood pressure
Not enough safety information about its risks available to be recommended as a safe supplement
Not established
Interactions
Interaction Checker
No Results
Contraindicated
Serious - Use Alternative
Significant - Monitor Closely
Minor
Contraindicated (0)
Serious - Use Alternative (0)
Monitor Closely (0)
Minor (24)
- acarbose
vanadium increases effects of acarbose by pharmacodynamic synergism. Minor/Significance Unknown.
- chlorpropamide
vanadium increases effects of chlorpropamide by pharmacodynamic synergism. Minor/Significance Unknown.
- digoxin
vanadium increases effects of digoxin by pharmacodynamic synergism. Minor/Significance Unknown.
- glimepiride
vanadium increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown.
- glipizide
vanadium increases effects of glipizide by pharmacodynamic synergism. Minor/Significance Unknown.
- glyburide
vanadium increases effects of glyburide by pharmacodynamic synergism. Minor/Significance Unknown.
- insulin aspart
vanadium increases effects of insulin aspart by pharmacodynamic synergism. Minor/Significance Unknown.
- insulin detemir
vanadium increases effects of insulin detemir by pharmacodynamic synergism. Minor/Significance Unknown.
- insulin glargine
vanadium increases effects of insulin glargine by pharmacodynamic synergism. Minor/Significance Unknown.
- insulin glulisine
vanadium increases effects of insulin glulisine by pharmacodynamic synergism. Minor/Significance Unknown.
- insulin lispro
vanadium increases effects of insulin lispro by pharmacodynamic synergism. Minor/Significance Unknown.
- insulin NPH
vanadium increases effects of insulin NPH by pharmacodynamic synergism. Minor/Significance Unknown.
- insulin regular human
vanadium increases effects of insulin regular human by pharmacodynamic synergism. Minor/Significance Unknown.
- metformin
vanadium increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown.
- miglitol
vanadium increases effects of miglitol by pharmacodynamic synergism. Minor/Significance Unknown.
- nateglinide
vanadium increases effects of nateglinide by pharmacodynamic synergism. Minor/Significance Unknown.
- pioglitazone
vanadium increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown.
- repaglinide
vanadium increases effects of repaglinide by pharmacodynamic synergism. Minor/Significance Unknown.
- rosiglitazone
vanadium increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown.
- saxagliptin
vanadium increases effects of saxagliptin by pharmacodynamic synergism. Minor/Significance Unknown.
- sitagliptin
vanadium increases effects of sitagliptin by pharmacodynamic synergism. Minor/Significance Unknown.
- tolazamide
vanadium increases effects of tolazamide by pharmacodynamic synergism. Minor/Significance Unknown.
- tolbutamide
vanadium increases effects of tolbutamide by pharmacodynamic synergism. Minor/Significance Unknown.
- vildagliptin
vanadium increases effects of vildagliptin by pharmacodynamic synergism. Minor/Significance Unknown.
Adverse Effects
Frequency Not Defined
Cramps
Diarrhea
Incr BP
Bipolar disorder
Warnings
Contraindications
Hypersensitivity
Cautions
Ability to determine vanadium deficiency or optimum dose not currently possible due to lack of studies
Pregnancy & Lactation
Pregnancy Category: N/A
Lactation: N/A
Pregnancy Categories
A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.
B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk. C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done. D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk. X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist. NA: Information not available.Pharmacology
Mechanism of Action
Blocks dozens of enzymes, including syntethases, kinases, and ribonucleasis
May improve sensitivity to insulin in type 1 and 2 diabetes
